AMGEVITA 40 mg0.8 ml solution for injection in pre-filled syringe Malásia - inglês - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

amgevita 40 mg0.8 ml solution for injection in pre-filled syringe

amgen biopharmaceuticals malaysia sdn bhd - adalimumab -

AMGEVITA 20 mg0.4 ml solution for injection in pre-filled syringe Malásia - inglês - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

amgevita 20 mg0.4 ml solution for injection in pre-filled syringe

amgen biopharmaceuticals malaysia sdn bhd - adalimumab -

MVASI Concentrate for Solution for Infusion 25 mgml Malásia - inglês - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

mvasi concentrate for solution for infusion 25 mgml

amgen biopharmaceuticals malaysia sdn bhd - bevacizumab -

AMGEVITA 40 mg0.8 ml solution for injection in pre-filled autoinjector Malásia - inglês - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

amgevita 40 mg0.8 ml solution for injection in pre-filled autoinjector

amgen biopharmaceuticals malaysia sdn bhd - adalimumab -

OTEZLA 10 MG Israel - inglês - Ministry of Health

otezla 10 mg

amgen europe b.v. - apremilast - film coated tablets - apremilast 10 mg - apremilast - otezla is indicated:- for treatment of adult patients with active psoriatic arthritis (psa).- for adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy (psor).- for the treatment of adult patients with oral ulcers associated with behçet’s disease (bd).

OTEZLA 10 MG Israel - inglês - Ministry of Health

otezla 10 mg

amgen europe b.v. - apremilast - film coated tablets - apremilast 10 mg - apremilast - otezla is indicated:- for treatment of adult patients with active psoriatic arthritis (psa).- for adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy (psor).- for the treatment of adult patients with oral ulcers associated with behçet’s disease (bd).

OTEZLA 10 MG Israel - inglês - Ministry of Health

otezla 10 mg

amgen europe b.v. - apremilast - film coated tablets - apremilast 10 mg - apremilast - otezla is indicated:- for treatment of adult patients with active psoriatic arthritis (psa).- for adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy (psor).- for the treatment of adult patients with oral ulcers associated with behçet’s disease (bd).

OTEZLA 10 MG Israel - inglês - Ministry of Health

otezla 10 mg

amgen europe b.v. - apremilast - film coated tablets - apremilast 10 mg - apremilast - otezla is indicated:- for treatment of adult patients with active psoriatic arthritis (psa).- for adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy (psor).- for the treatment of adult patients with oral ulcers associated with behçet’s disease (bd).

OTEZLA 10 MG Israel - inglês - Ministry of Health

otezla 10 mg

amgen europe b.v. - apremilast - film coated tablets - apremilast 10 mg - apremilast - otezla is indicated:- for treatment of adult patients with active psoriatic arthritis (psa).- for adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy (psor).- for the treatment of adult patients with oral ulcers associated with behçet’s disease (bd).

OTEZLA 10 MG Israel - inglês - Ministry of Health

otezla 10 mg

amgen europe b.v. - apremilast - film coated tablets - apremilast 10 mg - apremilast - otezla is indicated:- for treatment of adult patients with active psoriatic arthritis (psa).- for adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy (psor).- for the treatment of adult patients with oral ulcers associated with behçet’s disease (bd).